XML 175 R21.htm IDEA: XBRL DOCUMENT
v3.24.4

Stock Warrants | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2024 | Dec. 31, 2023
Stock Warrants [Abstract] |  |
Stock warrants | 13. Stock warrants As of September 30, 2024, there are 5,198,420 warrants outstanding. The warrants outstanding are exercisable, at an exercise price of $9.58 per share, for 1.034999 shares of Class A common stock. 7,349 warrants were exercised for 7,605 shares of Class A Common Stock during the nine months ended September 30, 2024. The warrants do not meet the criteria for equity treatment under ASC 815. As such, the warrants are classified as liabilities and are adjusted to fair value at the end of each reporting period. The Company remeasures the fair value of the warrants based on their quoted market price. The Company recognized a gain of $0.7 million for the three months ended September 30, 2024 and a loss of $1.7 million for the nine months ended September 30,2024 related to the change in fair value of warrant liabilities, which is recognized in Change in fair value of warrant liabilities in the unaudited condensed consolidated statements of operations and comprehensive income (loss). The following table summarizes the Company’s outstanding common stock warrants as of September 30, 2024:
Year of Issue |  | Number of Shares Issuable |  | Exercise Price |  | Expiration Date |  | Classification
2023 |  | 5,380,360 |  | 9.58 |  | 10/5/2028 |  | Liability
| 19. Stock warrants Immediately following the closing of the Business Combination there were 8,440,641 warrants outstanding. The warrants do not meet the criteria for equity treatment under ASC 815. As such, the warrants are classified as liabilities and are adjusted to fair value at the end of each reporting period. The Company remeasures the fair value of the warrants based on their quoted market price. For the year ended December 31, 2023, the Company recognized $3.0 million of losses related to the change in fair value of warrant liabilities, which is recognized in Change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive loss. The following table summarizes the Company’s outstanding common stock warrants as of December 31, 2023:
Year of Issue |  | Number of Shares Issuable |  | Exercise Price |  | Expiration Date |  | Classification
2023 |  | 5,387,966 |  | $ | 9.58 |  | Oct-2028 |  | Liability

X
- References No definition available. + Details
Name: | fbyd_StockWarrantsAbstract
Namespace Prefix: | fbyd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | fbyd_StockWarrantsTextBlock
Namespace Prefix: | fbyd_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration